Efficacy and safety of ibalizumab (IBA) in a Phase 3 study of heavily treatment-experienced patients with multi-drug resistant (MDR) HIV-1 infection.
Dec 25, 2016
25 Dec 2016
Lalezari J.
Location
Oral presentation #LB-6 at: IDWeek; Oct 26-30, 2016; New Orleans, Louisiana, USA.